Current Edition

Interview with Lawrence Friedhoff of Axovant Sciences
Volume 7 Issue 5

Interview with Lawrence Friedhoff of Axovant Sciences

JCS speaks with Lawrence Friedhoff, the Chief Development Officer of Axovant Sciences, about his involvement with the development of Donepezil, the most widely-used d...
Continue Reading →